Research & Evidence
Backed by peer‑reviewed studies, clinical trials, and safety data.
Peer‑Reviewed Studies
150+ publications validating exosome and regenerative efficacy.
Clinical Trials
Phase II/III outcomes show strong tissue regeneration and pain reduction.
FDA 21 CFR Part 1271
Comprehensive traceability, cGMP production, safety‑first protocols.
Exosome Applications in Regenerative Medicine
Comprehensive meta-analysis of extracellular vesicles for cartilage repair and anti-inflammatory signaling. Frontiers in Bioengineering & Biotechnology (2024).
Clinical Efficacy of MSC Therapy in Orthopedic Disorders
Randomized controlled trial demonstrating improved joint function and reduced pain with intra-articular MSCs. Stem Cell Research & Therapy (2023).
Exosomes vs. PRP for Musculoskeletal Regeneration
Comparative study showing superior outcomes for exosomal preparations in tendon and ligament healing. Journal of Translational Medicine (2024).
Systemic Safety Profile of Exosome Therapeutics
Review article summarizing 25+ human clinical studies evaluating safety, biodistribution, and immunogenicity. Nanomedicine (2023).
MSC-Derived Exosomes for Neurodegenerative Diseases
Emerging data on exosomal cargo modulation and neuroprotective pathways in Alzheimer’s and Parkinson’s disease. Cell Reports Medicine (2024).
Regulatory Frameworks for Stem Cell
Biologics
Comprehensive review of FDA 21 CFR 1271 and EMA ATMP compliance in regenerative medicine manufacturing. Regenerative Medicine (2023).